E

Epitomee Medical Ltd
TASE:EPIT

Watchlist Manager
Epitomee Medical Ltd
TASE:EPIT
Watchlist
Price: 919.8 ILS -1.01% Market Closed
Market Cap: 271.5m ILS
Have any thoughts about
Epitomee Medical Ltd?
Write Note

Epitomee Medical Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Epitomee Medical Ltd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
E
Epitomee Medical Ltd
TASE:EPIT
Total Liabilities & Equity
$40.3m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Total Liabilities & Equity
$218.6m
CAGR 3-Years
-3%
CAGR 5-Years
158%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Total Liabilities & Equity
$63m
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
13%
Inmode Ltd
NASDAQ:INMD
Total Liabilities & Equity
$824m
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Total Liabilities & Equity
$626.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Total Liabilities & Equity
$43.5m
CAGR 3-Years
108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Epitomee Medical Ltd
Glance View

Market Cap
271.5m ILS
Industry
Health Care

Epitomee Medical Ltd. develops and manufactures medical devices for obesity. The firm operates directly in the field of development, production and commercialization of medical platforms that are divided into two areas: the area of medical devices for weight loss and overweight, including the development and production of medical devices packed in capsules and ingested; the area of solutions for the introduction of drugs through ingestion that allows patients to take various medications that can be administered today only by injections. Both of the Company's solutions are intended for ingestion for patients for self-use, under a doctor's prescription and are under development.

EPIT Intrinsic Value
265.28 ILS
Overvaluation 71%
Intrinsic Value
Price
E

See Also

What is Epitomee Medical Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
40.3m USD

Based on the financial report for Dec 31, 2023, Epitomee Medical Ltd's Total Liabilities & Equity amounts to 40.3m USD.

What is Epitomee Medical Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 3Y
24%

Over the last year, the Total Liabilities & Equity growth was -27%. The average annual Total Liabilities & Equity growth rates for Epitomee Medical Ltd have been 24% over the past three years .

Back to Top